Flexion Therapeutics to Present at the H.C. Wainwright Virtual Healthcare Conference

Rhea-AI Summary

Flexion Therapeutics (Nasdaq: FLXN) has announced that Michael Clayman, M.D., CEO, will participate in an analyst-led fireside chat at the H.C. Wainwright Virtual Healthcare Conference on September 15, 2020, at 10:00 a.m. ET. Attendees can access the live webcast through the Flexion website. Flexion Therapeutics specializes in developing novel therapies for musculoskeletal conditions, starting with osteoarthritis, which is the most common form of arthritis.

BURLINGTON, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the H.C. Wainwright Virtual Healthcare Conference. The virtual fireside chat is scheduled to begin at 10:00 a.m. ET on Tuesday, September 15, 2020.  

To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.

About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Visit flexiontherapeutics.com.

Contact:

Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com

FAQ

When will Michael Clayman speak at the H.C. Wainwright Virtual Healthcare Conference for FLXN?

Michael Clayman will speak on September 15, 2020, at 10:00 a.m. ET.

How can I access the Flexion Therapeutics fireside chat webcast?

You can access the live webcast on the Flexion website prior to the event.

What is the focus of Flexion Therapeutics?

Flexion Therapeutics focuses on developing therapies for musculoskeletal conditions, with an emphasis on treating osteoarthritis.

What is the significance of the fireside chat for FLXN shareholders?

The fireside chat provides shareholders with insights into the company's strategy and developments in musculoskeletal treatments.